Related Experiment Videos
[Nitrate therapy during and after acute myocardial infarction]
Knud Landmark1, Asmund Reikvam
1Institutt for farmakoterapi, Universitetet i Oslo. k.h.landmark@labmed.uio.no
Summary
Intravenous nitroglycerin therapy for acute myocardial infarction shows benefits in hemodynamics and infarct size, but its impact on long-term prognosis remains uncertain. Current guidelines recommend its use in specific patient groups.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Nitrates have been used for over 130 years in treating ischemic heart disease.
- Acute myocardial infarction (AMI) management is a critical area in cardiovascular medicine.
Purpose:
- To review the literature on the benefits of nitrate therapy in patients with acute myocardial infarction.
- To evaluate the efficacy of intravenous nitroglycerin in improving outcomes after AMI.
Summary:
- Intravenous nitroglycerin demonstrates favorable hemodynamic effects and may reduce infarct size in AMI.
- While early studies suggested reduced mortality, newer research shows conflicting results, possibly due to variations in control group treatments and concomitant therapies like thrombolysis and antiplatelet agents.
- Current recommendations support intravenous nitroglycerin use within the first 24 hours of AMI, particularly for patients with recurrent ischemia, hypertension, or heart failure.
Impact:
- Clarifies the current understanding of nitrate efficacy in AMI, highlighting discrepancies in study outcomes.
- Provides evidence-based recommendations for the clinical application of nitroglycerin in acute myocardial infarction management.
- Informs future research directions regarding the role of nitrates in cardiovascular therapy.
Related Concept Videos
01:20Angina V: Nursing Management
284
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
284
01:26Angina IV: Management
232
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
232
01:26Acute Coronary Syndrome V: Nursing Management
262
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
262
01:28Acute Coronary Syndrome IV: Interprofessional Care
214
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
214
01:14Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
01:16Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K